Altres autors/es

Institut Català de la Salut

[Merino-Valverde I, Greco E, Abad M] Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Data de publicació

2021-11-11T10:07:18Z

2021-11-11T10:07:18Z

2020-06-01



Resum

Càncer; Micropèptid; Supressors de tumors


Cáncer; Micropéptido; Supresores de tumores


Cancer; Micropeptide; Tumor suppressors


Recent findings have revealed that many genomic regions previously annotated as non-protein coding actually contain small open reading frames, smaller that 300 bp, that are transcribed and translated into evolutionary conserved microproteins. To date, only a small subset of them have been functionally characterized, but they play key functions in fundamental processes such as DNA repair, RNA processing and metabolism regulation. This emergent field seems to hide a new category of molecular regulators with clinical potential. In this review, we focus on its relevance for cancer. Following Hanahan and Weinberg's classification of the hallmarks of cancer, we provide an overview of those microproteins known to be implicated in cancer or those that, based on their function, are likely to play a role in cancer. The resulting picture is that while we are at the very early times of this field, it holds the promise to provide crucial information to understand cancer biology.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

Elsevier

Documents relacionats

Experimental Cell Research;392

https://doi.org/10.1016/j.yexcr.2020.111997

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)